Pharmedium Recalls Vasopressin Injection Due to Manufacturing Deviations

Plain-English summary

Pharmedium Services, LLC has voluntarily recalled 72 bags of Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL). The recall was initiated on April 10, 2018, and is classified as Class III by the FDA. The reason for the recall is cited as current Good Manufacturing Practice (cGMP) deviations.

The affected product is identified by Lot 180660057S with an expiration date of June 5, 2018. The recall covers 72 bags that were distributed to Massachusetts and Washington. The recall was initiated by the firm and notified via telephone.

The FDA classifies this as a Class III recall, which means the product is not likely to cause adverse health consequences. The recall status is currently terminated as of January 14, 2020. Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above.

The recalled product

Product

Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL), Rx only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478

Manufacturer

Pharmedium Services, LLC

Category

Drug — Injection

Hazard

• cGMP-deviations

Affected units

72

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls